Peter B. Berger

Papers

Total Citations

H-Index

About

Dr. Peter B. Berger is a distinguished clinical researcher whose work has profoundly shaped the perioperative management of antithrombotic therapy, particularly in the context of urologic surgery. His key research areas include the safety of antiplatelet agents during surgical procedures and the optimization of patient outcomes in robot-assisted operations. Dr. Berger’s major contribution is his landmark study, "Preoperative Aspirin Is Safe in Patients Undergoing Urologic Robot-Assisted Surgery," which demonstrated that continuing aspirin before robot-assisted radical prostatectomy and nephrectomy does not significantly increase bleeding complications. This finding challenged long-standing clinical dogma and provided critical evidence supporting safer, evidence-based perioperative care, directly impacting thousands of surgical patients. With over 21 citations, this work has become a foundational reference for surgeons and anesthesiologists worldwide. Dr. Berger’s research is notable for its practical, patient-centered focus, bridging the gap between cardiovascular risk management and surgical safety. His achievements have established him as a leading voice in perioperative medicine, guiding clinicians to make informed decisions that reduce both thrombotic and hemorrhagic risks.